Sign in

CIK 0001720893

  • Non-accelerated filer
  • Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821386754
Phone
+1 203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion Director acquired 1,693 shares (option exercise)
  4. 4 Exercise or conversion Chief Financial Officer acquired 65 shares (option exercise)
  5. 4 Exercise or conversion Rodriguez Javier acquired 65 shares (option exercise)
  6. 4 Exercise or conversion Chief Scientific Officer acquired 65 shares (option exercise)
  7. 4 Exercise or conversion CEO and President acquired 379 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 1,693 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 27,089 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Director acquired 27,089 shares (option exercise)
  16. 4 Planned sale O'Neill Vincent sold 165 shares at $0.35 ($58)
  17. 4 Planned sale CEO and President sold 3,117 shares at an average $0.36 ($1,131)
  18. 4 Planned sale Chief Financial Officer sold 577 shares at an average $0.36 ($207)
  19. 4 Planned sale Rodriguez Javier sold 430 shares at an average $0.36 ($153)
  20. 4 Planned sale Chief Scientific Officer sold 430 shares at an average $0.35 ($152)

Page 4 of 14 · 276 filings